These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 11089976)

  • 21. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways.
    Park JI; Lee MG; Cho K; Park BJ; Chae KS; Byun DS; Ryu BK; Park YK; Chi SG
    Oncogene; 2003 Jul; 22(28):4314-32. PubMed ID: 12853969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Jun activation domain binding protein 1 expression is associated with low p27(Kip1)levels in node-negative breast cancer.
    Esteva FJ; Sahin AA; Rassidakis GZ; Yuan LX; Smith TL; Yang Y; Gilcrease MZ; Cristofanilli M; Nahta R; Pusztai L; Claret FX
    Clin Cancer Res; 2003 Nov; 9(15):5652-9. PubMed ID: 14654548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases.
    Touyz RM; Yao G
    J Cell Physiol; 2003 Dec; 197(3):326-35. PubMed ID: 14566962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
    Grau R; Iñiguez MA; Fresno M
    Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Jun activation domain-binding protein 1 expression in malignant lymphoma of the thyroid: its linkage to degree of malignancy and p27 expression.
    Ito Y; Yoshida H; Matsuzuka F; Matsuura N; Nakamura Y; Nakamine H; Kakudo K; Kuma K; Miyauchi A
    Anticancer Res; 2003; 23(5b):4121-5. PubMed ID: 14666612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor suppressor VDUP1 increases p27(kip1) stability by inhibiting JAB1.
    Jeon JH; Lee KN; Hwang CY; Kwon KS; You KH; Choi I
    Cancer Res; 2005 Jun; 65(11):4485-9. PubMed ID: 15930262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inverse expression of Jun activation domain binding protein 1 and cell cycle inhibitor p27Kip1: influence on proliferation in hepatocellular carcinoma.
    Berg JP; Zhou Q; Breuhahn K; Schirmacher P; Patil MA; Chen X; Schäfer N; Höller TT; Fischer HP; Büttner R; Gütgemann I
    Hum Pathol; 2007 Nov; 38(11):1621-7. PubMed ID: 17651785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The S100A7-c-Jun activation domain binding protein 1 pathway enhances prosurvival pathways in breast cancer.
    Emberley ED; Niu Y; Curtis L; Troup S; Mandal SK; Myers JN; Gibson SB; Murphy LC; Watson PH
    Cancer Res; 2005 Jul; 65(13):5696-702. PubMed ID: 15994944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macrophage migration inhibitory factor does not modulate co-activation of androgen receptor by Jab1/CSN5.
    Berndt K; Kim M; Meinhardt A; Klug J
    Mol Cell Biochem; 2008 Jan; 307(1-2):265-71. PubMed ID: 17786542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Receptor binding and cellular uptake studies of macrophage migration inhibitory factor (MIF): use of biologically active labeled MIF derivatives.
    Kleemann R; Grell M; Mischke R; Zimmermann G; Bernhagen J
    J Interferon Cytokine Res; 2002 Mar; 22(3):351-63. PubMed ID: 12034043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural characterization of As-MIF and hJAB1 during the inhibition of cell-cycle regulation.
    Park YH; Jeong MS; Ha KT; Yu HS; Jang SB
    BMB Rep; 2017 May; 50(5):269-274. PubMed ID: 28366190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of p27(Kip1) and c-Jun activation binding protein 1 are inversely correlated in systemic anaplastic large cell lymphoma.
    Rassidakis GZ; Claret FX; Lai R; Zhang Q; Sarris AH; McDonnell TJ; Medeiros LJ
    Clin Cancer Res; 2003 Mar; 9(3):1121-8. PubMed ID: 12631617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cytoplasmic shuttling and subsequent degradation of p27Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex.
    Tomoda K; Kubota Y; Arata Y; Mori S; Maeda M; Tanaka T; Yoshida M; Yoneda-Kato N; Kato JY
    J Biol Chem; 2002 Jan; 277(3):2302-10. PubMed ID: 11704659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A 16-residue peptide fragment of macrophage migration inhibitory factor, MIF-(50-65), exhibits redox activity and has MIF-like biological functions.
    Nguyen MT; Beck J; Lue H; Fünfzig H; Kleemann R; Koolwijk P; Kapurniotu A; Bernhagen J
    J Biol Chem; 2003 Sep; 278(36):33654-71. PubMed ID: 12796500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. JAB1/CSN5 and the COP9 signalosome. A complex situation.
    Chamovitz DA; Segal D
    EMBO Rep; 2001 Feb; 2(2):96-101. PubMed ID: 11258719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Jab1 interacts with brain-specific kinase 2 (BRSK2) and promotes its degradation in the ubiquitin-proteasome pathway.
    Zhou J; Wan B; Li R; Gu X; Zhong Z; Wang Y; Yu L
    Biochem Biophys Res Commun; 2012 Jun; 422(4):647-52. PubMed ID: 22609399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Jab1 co-activation of c-Jun is abrogated by the serine 10-phosphorylated form of p27Kip1.
    Chopra S; Fernandez De Mattos S; Lam EW; Mann DJ
    J Biol Chem; 2002 Sep; 277(36):32413-6. PubMed ID: 12119282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction and colocalization of PGP9.5 with JAB1 and p27(Kip1).
    Caballero OL; Resto V; Patturajan M; Meerzaman D; Guo MZ; Engles J; Yochem R; Ratovitski E; Sidransky D; Jen J
    Oncogene; 2002 May; 21(19):3003-10. PubMed ID: 12082530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COP9 signalosome-directed c-Jun activation/stabilization is independent of JNK.
    Naumann M; Bech-Otschir D; Huang X; Ferrell K; Dubiel W
    J Biol Chem; 1999 Dec; 274(50):35297-300. PubMed ID: 10585392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Jab1/COP9 signalosome subcomplex is a downstream mediator of Bcr-Abl kinase activity and facilitates cell-cycle progression.
    Tomoda K; Kato JY; Tatsumi E; Takahashi T; Matsuo Y; Yoneda-Kato N
    Blood; 2005 Jan; 105(2):775-83. PubMed ID: 15353483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.